Skip to content
Research Article Open access CC BY 3.0

Determination of Vancomycin and Methicillin Resistance in Clinical Isolates of Staphylococcus aureus in Iranian Hospitals

Abbas Farhadian, Qorban Behzadian Nejad, Shahin Najar peerayeh, Mohammad Rahbar, Farzam Vaziri

Microbiology Research Journal International · pp. 454–461 · Published 12 Jan 2014

10.9734/BMRJ/2014/4836

Abstract

Aims: The aim of this study was to determine the prevalence of methicillin resistant S. aureus (MRSA), vancomycin resistant or vancomycin intermediate resistant S. aurues (aureus) (VRSA/VISA) among clinical isolates. Study Design: S.aureus isolates used in this study were randomly collected from in-patient and outpatient of several hospitals of 7 cities in Iran (Tehran, Shiraz, Zahedan, Tabriz, Sannandaj, Sari, and Ahvaz) during 2006-2008. Methodology: Antibiotic susceptibility of 250 strains of Staphylococcus aureus isolated from Iranian hospitals were determined by disk diffusion method. Minimum inhibitory concentration (MICs) were determined for oxacillin and vancomycin by E-test. PCRs were used by specific primers (PCR used specific primers) for detection of mecA, vanA, vanB genes. Results: The percentage of resistance by disk diffusion method was as below: methicillin 46%, vancomycin 0%, penicillin 86%, erythromycin 42%, ciprofloxacin 29%, gentamicin 39% and clindamycin 33%. E-test MIC method showed that 43% isolates were resistant to methicillin and 4% isolates were VISA (≤ 8µg/ml). The prevalence of resistance genes in the clinical isolates were: mecA 44%, vanA 0%, vanB 0%. Conclusion: This study revealed that clinical isolates have rather high resistance to methicillin, erythromycin, gentamicin, penicillin and clindamycin We did not observe resistance to vancomycin. In order to avoid a possible outbreak involving VISA), vancomycin should be used carefully as a drug for treatment of S. aureus infections.

S. aureus MRSA VRSA VISA E-test PCR

References (22)

  1. 1 Clinical and Laboratory Standards Institute [DOI]
  2. 2 The Changing Epidemiology of Staphylococcus aureus ? [DOI]
  3. 3 Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus [DOI]
  4. 4 Staphylococcus aureus: A Well–Armed Pathogen [DOI]
  5. 5 Multiplex PCR Assay for Simultaneous Detection of Nine Clinically Relevant Antibiotic Resistance Genes in Staphylococcus aureus [DOI]
  6. 6 Emergence of vancomycin resistant Staphylococcus aureus(VRSA) from a tertiary care hospital from northern part of India [DOI]
  7. 7 Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus [DOI]
  8. 8 Related Clones Containing SCC mec Type IV Predominate among Clinically Significant Staphylococcus epidermidis Isolates [DOI]
  9. 9 Community-acquired methicillin-resistant Staphylococcus aureus infections [DOI]
  10. 10 Genetic Characterization of a Vancomycin-Resistant Staphylococcus aureus Isolate from the Respiratory Tract of a Patient in a University Hospital in Northeastern Iran [DOI]
  11. 11 Vancomycin-Resistant Staphylococcus aureus Isolates Associated with Inc18-Like vanA Plasmids in Michigan [DOI]
  12. 12 Antibiotic resistance in Gram-positive bacteria: epidemiological aspects [DOI]
  13. 13 High Level Oxacillin and Vancomycin Resistance and Altered Cell Wall Composition in Staphylococcus aureus Carrying the Staphylococcal mecA and the Enterococcal vanA Gene Complex [DOI]
  14. 14 Principles and Practice of Clinical Bacteriology
  15. 15 Carriage of Methicillin-Resistant Staphylococci and Their SCC mec Types in a Long-Term-Care Facility [DOI]
  16. 16 Mechanisms of Resistance to Beta-lactam Antibiotics in Strains of Staphylococcus aureus [DOI]
  17. 17 Prevalence of the Genes Encoding Aminoglycoside-Modifying Enzymes and Methicillin Resistance Among Clinical Isolates of Staphylococcus aureus in Tehran, Iran [DOI]
  18. 18 High Percentage of Methicillin-ResistantStaphylococcus aureusIsolates with Reduced Susceptibility to Glycopeptides in The Netherlands [DOI]
  19. 19 High-Level Vancomycin-Resistant Staphylococcus aureus (VRSA) in Iran: A Systematic Review
  20. 20 Sensitivity pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates, against several antibiotics including tigecycline in Iran: a hospital based study.
  21. 21 Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000-2002) [DOI]
  22. 22 Sensitivity of Staphylococcus aureus Strains Isolated from Clinical Specimens against Vancomycin by Using E-test in Tabriz

Cited by 19

Molecular Mechanisms of Fosfomycin Resistance in MDR Escherichia coli Isolates from Urinary Tract Infections

Rehab Bahy, W. A. Abu El-Wafa, A. Abouwarda · The Egyptian Journal of Medical Microbiology · 2023

The Expression of Efflux Pump Genes in Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated from Blood Cultures in Iran

Arezoo Bostanmaneshrad, J. Nowroozi, G. Eslami · Archives of Clinical Infectious Diseases · 2020

Phenotypic and Molecular Identification of Vancomycin Resistance in Clinical Staphylococcus Aureus Isolates in Osogbo, Nigeria

B. T. Bamigboye, O. Olowe, S. Taiwo · European Journal of Microbiology & Immunology · 2018

Article metrics

Real usage data collected on this platform.

102

Page views

0

PDF downloads

12

Outbound clicks

19

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.